Nuestro enfoque ante las afecciones neurovasculares
The Montefiore Einstein Comprehensive Neurovascular Center is one of the leading destinations worldwide for the management of vascular diseases of the brain and spine, including ischemic and hemorrhagic strokes, venous occlusive disease, vascular malformations, subarachnoid hemorrhages, traumatic injuries and congenital conditions. We are the first health system from the Bronx to the Hudson Valley to have earned the prestigious Comprehensive Stroke Center designation from the Joint Commission and are among the top three percent of hospitals in the nation to earn this designation. We are the highest-volume stroke center in the New York metropolitan region and treat one of the most diverse communities in the nation, including pediatric and adult stroke patients, with state-of-the-art care and emerging technology. We are ranked in the top 1% of all hospitals in the nation for neurology and neurosurgery, according to U.S. News & World Report.
We use the latest and most advanced imaging tools and procedures to treat patients of all ages suffering from complex, life-threatening neurovascular conditions. Our neurovascular program offers a complete array of state-of-the-art solutions for the full spectrum of neurovascular diseases, including endovascular, open, minimally invasive, and hybrid surgeries.
Leading Stroke Research, Clinical Trials & Education
An internationally recognized leader in stroke research, Montefiore Einstein is a founding partner and key member of the New York City Collaborative Regional Coordinating Center (NYC-RCC), the largest National Institutes of Health (NIH)-funded, multi-institutional consortium dedicated to stroke prevention, treatment, education and rehabilitation efforts to reduce the burden of stroke on children and adults throughout the country. Distinguished as an NIH StrokeNet Regional Coordinating Center since the inception of the NIH StrokeNet in 2013, we are among an elite group of only 27 centers in the nation to be awarded a five-year grant, funded by the National Institute of Neurological Disorders and Stroke (NINDS)/NIH. We spearhead and participate in numerous clinical trials to advance promising interventions for stroke prevention, treatment, recovery and rehabilitation for patients with or at risk of a stroke across all stages of life.
A collaborative effort between the NIH and Montefiore Einstein, the Icahn School of Medicine at Mount Sinai, New York University School of Medicine and other affiliated institutions and partner sites, our Regional Coordinating Center encompasses all boroughs of New York City, Westchester, Long Island and Upstate New York, as well as Nashville, TN, and we continue to expand our network. We also continue to develop interdisciplinary endovascular platforms, new devices and intersectional strategies for conducting ultra-rapid clinical trials.
At the Montefiore Einstein Comprehensive Neurovascular Center we are also leaders in education, advancing programs and training for the next generation of top multidisciplinary experts in stroke care.
Experiencia reconocida
The Montefiore Einstein Comprehensive Neurovascular Center team is led by nationally renowned vascular neurologists, neurosurgeons and neuroradiologists. Our multidisciplinary team members have advanced fellowship training, experience and expertise in the latest technologies and techniques for treating strokes, aneurysms and vascular malformations, among other conditions. We are also one of few centers in the nation whose specialists in all three departments have been trained through fellowship programs focused on endovascular techniques.
Tratamientos avanzados
The Montefiore Einstein Comprehensive Neurovascular Center team is led by nationally renowned vascular neurologists, neurosurgeons and neuroradiologists. Our multidisciplinary team members have advanced fellowship training, experience and expertise in the latest technologies and techniques for treating strokes, aneurysms and vascular malformations, among other conditions. We are also one of few centers in the nation whose specialists in all three departments have been trained through fellowship programs focused on endovascular techniques.
Patients are initially evaluated by neurologists with subspecialty training in stroke and endovascular neurology. They will determine if the patient needs urgent medical treatment, minimally invasive endovascular treatment, or open surgical or neurosurgical treatment.
Aneurismas
There are a range of surgical options for treating aneurysms, each with its own benefits and requirements for postoperative follow-up and care. Based on an individualized approach, each patient’s unique needs are considered during the consultation to determine the most promising outcome.
Malformaciones arteriovenosas
For patients with arteriovenous malformation (AVM), the following treatment options can achieve a stand-alone cure. However, a combined approach is often most effective. The goal of any treatment option is to completely disconnect the connections to achieve a total cure. Only a total cure will eliminate the risk of bleeding.
Moyamoya Disease
Some rare conditions cannot be fully cured, as they interfere with blood vessels (internal carotid arteries) that supply blood to the brain. One such diagnosis is Moyamoya disease, which results in an increased risk of stroke and brain bleeding. However, patients diagnosed with Moyamoya disease may benefit from surgery that can reduce these risks.
Investigación y ensayos clínicos
An NIH StrokeNet Regional Coordinating Center, Montefiore Einstein Comprehensive Stroke Center participates in several NIH- and industry-funded stroke clinical trials and registries. In 2020, the vascular neurology and neurological surgery faculty published 30 articles in peer-reviewed journals, including many describing the novel aspects of stroke associated with COVID-19.
Su equipo del Centro Neurovascular Integral
About Stroke & Other Neurovascular Conditions
Los trastornos neurovasculares, incluidos los aneurismas cerebrales, las malformaciones arteriovenosas (MAV), la enfermedad de la arteria carótida y la enfermedad aterosclerótica intracraneal, son afecciones que afectan el suministro de sangre al cerebro o la médula espinal. Las obstrucciones en las arterias que irrigan el cerebro pueden provocar diversos problemas neurológicos, desde un accidente cerebrovascular hasta discapacidad e incluso la muerte. Las enfermedades neurovasculares son una de las principales causas de discapacidad en adultos.
Un accidente cerebrovascular (ACV) es un ataque al cerebro. Se trata de una interrupción repentina del flujo continuo de sangre al cerebro y constituye una emergencia médica. Un ACV se produce cuando un vaso sanguíneo del cerebro se obstruye o se estrecha, o cuando un vaso sanguíneo se rompe y derrama sangre en el cerebro. Al igual que un ataque al corazón, un ACV requiere atención médica inmediata.